These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25270749)

  • 21. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential impact of exclusion criteria on results of hypertension trials.
    Remington RD
    Hypertension; 1989 May; 13(5 Suppl):I66-8. PubMed ID: 2490830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Introduction of a User-oriented Application for Biometrical Sample Size Calculation in Clinical and Epidemiological Trials].
    Geis B; Tulka S; Knippschild S; Krummenauer F
    Klin Monbl Augenheilkd; 2021 Feb; 238(2):179-185. PubMed ID: 31117147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consultants' forum: should post hoc sample size calculations be done?
    Walters SJ
    Pharm Stat; 2009; 8(2):163-9. PubMed ID: 18416448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Power and sample size calculations for stochastic cost-effectiveness analysis.
    Briggs AH; Gray AM
    Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval.
    Liu GF; Zhu GR; Cui L
    Stat Med; 2008 Feb; 27(4):584-96. PubMed ID: 17634972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive statistical analysis following sample size modification based on interim review of effect size.
    Hung HM; Cui L; Wang SJ; Lawrence J
    J Biopharm Stat; 2005; 15(4):693-706. PubMed ID: 16022173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of statistical power for confidence intervals.
    Liu XS
    Br J Math Stat Psychol; 2012 Nov; 65(3):427-37. PubMed ID: 22026811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications.
    Röhrig B; du Prel JB; Wachtlin D; Kwiecien R; Blettner M
    Dtsch Arztebl Int; 2010 Aug; 107(31-32):552-6. PubMed ID: 20827353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical analysis for two-stage seamless design with different study endpoints.
    Chow SC; Lu Q; Tse SK
    J Biopharm Stat; 2007; 17(6):1163-76. PubMed ID: 18027223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Test Statistics and Confidence Intervals to Establish Noninferiority between Treatments with Ordinal Categorical Data.
    Zhang F; Miyaoka E; Huang F; Tanaka Y
    J Biopharm Stat; 2015; 25(5):921-38. PubMed ID: 24919157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Bayesian approach on sample size calculation for comparing means.
    Wang H; Chow SC; Chen M
    J Biopharm Stat; 2005; 15(5):799-807. PubMed ID: 16078386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sample size for short-term trials of antihypertensive drugs.
    Freestone S; Silas JH; Ramsay LE
    Br J Clin Pharmacol; 1982 Aug; 14(2):265-8. PubMed ID: 7104177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size calculations.
    Noordzij M; Dekker FW; Zoccali C; Jager KJ
    Nephron Clin Pract; 2011; 118(4):c319-23. PubMed ID: 21293154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size calculations in thorough QT studies.
    Zhang L; Dmitrienko A; Luta G
    J Biopharm Stat; 2008; 18(3):468-82. PubMed ID: 18470756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flexible design of two-stage adaptive procedures for phase III clinical trials.
    Koyama T
    Contemp Clin Trials; 2007 Jul; 28(4):500-13. PubMed ID: 17307399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimators and confidence intervals for the proportion using binary auxiliary information with applications to pharmaceutical studies.
    Rueda M; Muñoz JF; Arcos A; Álvarez E; Martínez S
    J Biopharm Stat; 2011 May; 21(3):526-54. PubMed ID: 21442524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On sample size calculation for 2x2 fixed-effect ANOVA when variances are unknown and possibly unequal.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):417-25. PubMed ID: 18559139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.